| Application no. and date | 17203276.5 (espacenet) (Federated) (European Patent Register), 20171123 | | Patent/reg. no. and date | DK/EP 3488868, 20230913 | | Publication date | 20190529 | | Priority no. and date | | | EP pub. no. and date |
EP 3488868 20190529 | | Effective date | | | Applicant/owner | medac Gesellschaft für klinische Spezialpräparate mbH, Theaterstrasse 6
22880 Wedel, DE | | Applicant ref. no. | 168957/BT/GP | | Inventor | BIALLECK, Sebastian, medac GmbH
Theaterstr. 6
22880 Wedel, DE,
Mensonides-Harsema, Marguérite M., 1819 Latexo Drive
Houston, Texas 77018, US,
Schuldt-Lieb, Sonja, medac GmbH
Theaterstr. 6
22880 Wedel, DE | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 47/14 (2017.01) , A61K 47/18 (2017.01) , A61K 9/08 (2006.01) , A61P 1/00 (2006.01) , A61P 19/02 (2006.01) , A61P 29/00 (2006.01) | | Title | Farmaceutisk sammensætning til oral indgivelse, som indeholder sulfasalazin og/eller et organisk sulfasalazinsalt, fremstillingsfremgangsmåde samt anvendelse | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
